Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence: Table 1
出版年份 2010 全文链接
标题
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence: Table 1
作者
关键词
-
出版物
CLINICAL SCIENCE
Volume 120, Issue 8, Pages 307-319
出版商
Portland Press Ltd.
发表日期
2010-12-24
DOI
10.1042/cs20100389
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Matrix Metalloproteinase Control of Capillary Morphogenesis
- (2012) Cyrus M. Ghajar et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis
- (2010) Nicolas Clere et al. INTERNATIONAL JOURNAL OF CANCER
- Protection of retinal vasculature by losartan against apoptosis and vasculopathy in rats with spontaneous hypertension
- (2010) Deye Yang et al. JOURNAL OF HYPERTENSION
- Bevacizumab and breast cancer: the E2100 outlier
- (2010) Tito Fojo et al. LANCET ONCOLOGY
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells
- (2010) Qiaoke Gong et al. PANCREAS
- Captopril as a Potential Inhibitor of Lung Tumor Growth and Metastasis
- (2009) Samir Attoub et al. Annals of the New York Academy of Sciences
- Telmisartan induces proliferation of human endothelial progenitor cells via PPARγ-dependent PI3K/Akt pathway
- (2009) Atsushi Honda et al. ATHEROSCLEROSIS
- Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma
- (2009) Andréia Hanada Otake et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Regenerative Therapy in Peripheral Artery Disease
- (2009) Antonia Germani et al. Cardiovascular Therapeutics
- Involvement of Angiotensin II-Dependent Vascular Endothelial Growth Factor Gene Expression via NADPH Oxidase in the Retina in a Type 2 Diabetic Rat Model
- (2009) Masanori Fukumoto et al. CURRENT EYE RESEARCH
- Current Molecular Understanding and Future Treatment Strategies for Pathologic Ocular Neovascularization
- (2009) Michael Tolentino CURRENT MOLECULAR MEDICINE
- Peptides Targeting Angiogenesis Related Growth Factor Receptors
- (2009) Luca D'Andrea et al. CURRENT PHARMACEUTICAL DESIGN
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats
- (2009) Maxim Krikov et al. JOURNAL OF HYPERTENSION
- Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs
- (2009) Hans-Christoph Diener JOURNAL OF HYPERTENSION
- Angiotensin II Type 1 Receptor Blocker Telmisartan Reduces Cerebral Infarct Volume and Peri-infarct Cytosolic Phospholipase A2 Level in Experimental Stroke
- (2009) Tomonori Kobayashi et al. JOURNAL OF NEUROTRAUMA
- Angiotensin AT1 Receptor Antagonism Ameliorates Murine Retinal Proteome Changes Induced by Diabetes
- (2009) Ben-Bo Gao et al. JOURNAL OF PROTEOME RESEARCH
- Role of Angiotensin II Type 1 Receptor on Retinal Vascular Leakage in a Rat Oxygen-Induced Retinopathy Model
- (2009) Hiroaki Nakamura et al. OPHTHALMIC RESEARCH
- AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
- (2009) D. R. Rhodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Candesartan Augments Ischemia-Induced Proangiogenic State and Results in Sustained Improvement After Stroke
- (2009) Anna Kozak et al. STROKE
- A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
- (2009) Guo-Cai Lu et al. STROKE
- Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy
- (2008) ELENA FAVARO et al. APMIS
- Therapeutic Angiogenesis
- (2008) Anna Ahn et al. Cardiology in Review
- AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy
- (2008) Laura E. Downie et al. GLIA
- Potential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer
- (2008) D. Herr et al. GYNECOLOGIC ONCOLOGY
- Attenuation of Focal Brain Ischemia by Telmisartan, an Angiotensin II Type 1 Receptor Blocker, in Atherosclerotic Apolipoprotein E-Deficient Mice
- (2008) Masaru IWAI et al. HYPERTENSION RESEARCH
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors
- (2008) Sebastien Faure et al. JOURNAL OF HYPERTENSION
- Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study
- (2008) W. Kozak et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
- (2008) Nish Chaturvedi et al. LANCET
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
- (2008) Anne Katrin Sjølie et al. LANCET
- Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents
- (2008) Silvia De la Iglesia Iñigo et al. LEUKEMIA RESEARCH
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
- (2008) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temporary Pretreatment With the Angiotensin II Type 1 Receptor Blocker, Valsartan, Prevents Ischemic Brain Damage Through an Increase in Capillary Density
- (2008) Jian-Mei Li et al. STROKE
- Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis
- (2007) Ping Li et al. HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now